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Abstract
Background: Both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are important viral pathogens
causing respiratory tract infection (RTI) in the pediatric population. However, the clinical manifestations of RSV and
hMPV infections are similar. Therefore, a reliable and rapid diagnostic tool is needed for diagnostic performance.
Methods: In order to optimize diagnosis efficiency of RTI, the aim of this study is to establish a rapid and advanced
method for simultaneous detecting RSV and hMPV in nasopharyngeal aspirates specimens from patients. We designed
a one-step triplex real-time RT-PCR (qRT-PCR) protocol using TaqMan probes for detecting RSV and hMPV. The plasmid
clones containing RSV nucleoprotein gene and hMPV fusion gene were established as reference standards. We used
virus culture supernatants from 86 known pediatric RTI patient to test the specificity and sensitivity of our assay. Then
we used total 222 nasopharyngeal aspirates specimens from pediatric patients hospitalized with respiratory symptoms
to evaluate our assay.
Results: Our one-step triplex qRT-PCR assay showed 100% sensitivity and specificity in testing RSV and hMPV in 86
known virus culture supernatants, with excellent linearity (R2 > 0.99) and reliable reproducibility (CV lower than 1.04%).
This assay has a wide dynamic range 102-109copies/reaction (limit of detection; LOD = 100 copies/reaction). A total of
222 patients hospitalized with respiratory symptoms were enrolled for clinical evaluation. In these samples, our qRT-PCR
assay detected 68 RSV positive and 18 hMPV positive cases. However, standard virus culture only detected 8 RSV positive
cases and 0 hMPV cases. Based on this improved triplex qRT-PCR assay, we found that RSV infection was associated with
severe inflammation by chest X-ray and occurrence of pneumonia which were not observed previously.
Conclusions: In summary, we have developed a highly specific and sensitive one-step triplex qRT-PCR assay to detect
hMPV and RSV simultaneously. This assay offers a valuable tool for routine diagnosis.
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Background
Acute respiratory tract infection (RTI) is estimated to be
the second important cause of death throughout the
world among children less than 5 years old [1]. Both re-
spiratory syncytial virus (RSV) and human metapneumo-
virus (hMPV) are important viral pathogens inducing
RTI [2–4]. RSV and hMPV are non-segmented, negative-
strand, enveloped RNA viruses. Both of them are classified
within the Pneumovirinae subfamily of the Paramyxoviridae
family. RSV is implicated in the majority of respiratory tract
infection, which accounts for 60–80% of the bronchiolitis
cases in children below 12 months of age [5]. Recently, it has
been demonstrated that hMPV also causes acute respiratory
tract infections, similar to RSV [1, 6]. hMPV was first identi-
fied in 2001 from a pediatric patient with respiratory diseases
in the Netherlands [7]. hMPV causes a wide spectrum of dis-
ease ranging from mild upper RTI to more severe lower RTI
such as bronchiolitis or pneumonia. Second to RSV, hMPV
causes bronchiolitis and accounts for 5–15% of child hospi-
talizations for RTI [8, 9].
Both RSV and hMPV infections induce disruption of
respiratory epithelial architecture, sloughing of epithelial
cells, loss of cilation and acute pulmonary inflammation
characterized by alveolitis, interstitial inflammation and
peribronchiolitis [7, 9]. Following, acute otitis media is
the most common complication of RTI due to RSV or
hMPV [8]. At present, the initial clinical manifestations of
RSV are indistinguishable from those of hMPV [10–12].
One possible reference to distinguish RSV and hMPV in-
fections is based on the epidemiological data. The median
age of hMPV-positive hospitalized patients is 6-12
months, which is significantly higher than that of
RSV (2-3 months) [13].
RSV and hMPV do not appear to be significantly asso-
ciated with asymptomatic carriage in the respiratory
tract of healthy persons. However, the diagnosis effi-
ciency for these 2 virus infection is low using the clas-
sical virus culture methods. Both viruses are labile in the
environment and are susceptible to drying [14]. For viral
culture, RSV can growth in the HEp-2, A549, or Vero
cells and usually takes 3–5 days to revealing characteris-
tic syncytial cytopathic pattern [7, 15–17]. In contrast,
hMPV can growth in the LLC-MK2 cells. The growth of
hMPV is slow and often requires several blind passages
before any cytopathic effect (CPE) is apparent, particu-
larly following primary isolation, which often takes more
than 10 days [18]. These lengthy viral culture processes,
in part, limited the opportunity for optimal initial diag-
nosis and the following therapeutic adjustment for RTI
patient. Therefore, a reliable and rapid diagnostic tool is
needed. Rapid and accurate laboratory diagnosis of viral
RTI is crucial for optimal clinical management, dimin-
ishes unnecessary use of antibiotics, and allows for use
of antivirals when appropriate.
Objectives
The aim of this study is to design and assess the diagnostic
performance of clinical specimens for the simultaneous
identification of RSV and hMPV by using one-step triplex
qRT-PCR assay with TaqMan probes. To this aim, we first
performed our primer and probe design. Then we used
cultured viruses to evaluate the specificity of our primers
using qRT-PCR. Finally, we used this established qRT-
PCR assay to detect the viral load in nasopharyngeal
aspirates.
Methods
Primers and probe design
The primers and probes for RSV, hMPV and GAPDH
were designed by Primer 3 website (http://bioinfo.ut.ee/
primer3-0.4.0/primer3/). We selected RSV nucleoprotein
gene conserved regions as a target for our RSV primer
and probe designs. For hMPV, we selected hMPV fusion
protein gene conserved regions as a target for our pri-
mer and probe designs. The target sequence of our pri-
mer and probe designs was showed in Table 1. The
Table 1 Design of the one-step triplex qRT-PCR assays for the detection of RSV, hMPV and Internal Control
Virus Target gene Name of primer or probe Sequence (5′→ 3′) Position
RSV Nucleoprotein RSV-F TGATACACTSAACAAAGATCAACTTCTG 27–54a
RSV-R TCTCCTGTGCTMCGTTGRAT 73–92a
RSV-probe VIC-CATCCAGCAAATACAC-MGBNFQ 56–71a
hMPV Fusion protein hMPV-F TCAGAATGCAGGGTCAACTGTT 156–177b
hMPV-R GACATGGTCTCCTCTTGTTTCACA 199–222b
hMPV-probe FAM-CAAGCTTCCCGTTCTCAGCC-MGBNFQ 179–197b
Internal Control GAPDH GAPDH-F GAAGGTGAAGGTCGGAGTC 108–126c
GAPDH-R GAAGATGGTGATGGGATTTC 314–333c
GAPDH-probe NED-CAAGCTTCCCGTTCTCAGCC-MGBNFQ 285–304c
aGenBank Accession no. DQ780565.1
bGenBank Accession no. AY295956.1
cGenBank Accession no. NM_002046
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specificity of these primer and probe sequences were
tested by the BLAST algorithm.
To rapidly and accurately quantify the RSV and hMPV
in nasopharyngeal aspirates, we combined 3 single qRT-
PCR, amplifying RSV, hMPV and GAPDH (internal con-
trol), in a one-tube reaction. For this one-tube reaction,
the probe for RSV was labeled with the dye VIC dye at
its 5′ end and minor groove binder (MGB) at its 3′end.
The probe for hMPV was labeled with the reporter 6-
carboxyfluorescein (FAM) dye at its 5′ end and MGB at
its 3′ end. The probe for GAPDH was labeled with NED
dye at its 5′ end and MGB at its 3′ end. RSV, hMPV and
GAPDH amplification signals were separately detected
by the VIC, FAM and NED channels by multi-channel
qRT-PCR detection system. The primers for direct se-





Virus culture and immunofluorescence assay
In brief, sterile beads were added to the samples, vor-
texed and processed routinely followed by centrifuged at
2000 rpm for 7 min. Specimens were then decontami-
nated by adding a 10% antibiotic mixture (Gibco,
N.Y.USA) and incubating for 1 h at 4 °C. A volume of
200 μL of sample was inoculated into each of the follow-
ing cell lines: MRC-5, HEp2, RD, MDCK, and LLCMK2
(ATCC, Manassas, VA, USA). One μΛ of maintenance
medium (minimal essential medium with 1% fetal bovine
serum) (Gibco, N.Y.USA) was added to each cell line
and incubated at 37 °C for 14 days. The CPE was ob-
served every other working day by inverted light micros-
copy (Olympus, Japan). After CPE appeared, cell smears
were prepared and fixed in chilled acetone at −20 °C for
10 min and then tested by fluorescein-conjugated mono-
clonal antibody in a direct immunofluorescence assay
(D3 Ultra 8TM DFA Respiratory Virus Screening & ID
Kit, Diagnostic Hybrids, USA). Stained cell smears were
examined in a fluorescence microscope at 400× magnifi-
cation (Olympus, Japan). Un-inoculated cell smear was
used as negative control.
Reference standard
To establish reference standards for RSV and hMPV
viral load, we established 2 plasmid clones containing
RSV nucleoprotein gene sequence and hMPV fusion
protein gene sequence. These plasmids were amplified
and cloned into a pCR® 2.1-TOPO® cloning vector using
a TOPO TA cloning kit for sequencing (Invitrogen,
Carlsbad, CA). Sequencing of the cloned insert established
the fidelity of the sequence. Plasmid DNA containing each
fragment sequence was purified, linearized by restriction
enzyme digestion. The concentration of DNA was
measured at least four times by a spectrophotometer
(IMPLEN NanoPhotometer™, CA, USA), and the numbers
of copies per μL were calculated using the mean values
and the following formula: [(g/μL DNA)/(length × 660)] ×
6.022 × 1023, where the length is the number of nucleo-
tides. Tenfold dilutions equivalent to 102 to 109 copies/re-
action of plasmid were used to determine the limit of
detection (LOD) of the one-step triplex qRT-PCR assay.
Sample collection
This study included infants (<24 months) and young
children (<6 years old) admitted to the pediatric depart-
ment of Kaohsiung Chang Gung Memorial Hospital.
Children and infants were eligible if identified as having
one or more of the following symptoms: difficulty in
breathing, nasal discharge, blocked nose, cough, or fast
breathing for age. Nasopharyngeal aspirates were pro-
spectively collected from November, 2010 to August,
2011. Informed consent was signed from the parent/
guardian of each child. The nasopharyngeal aspirates
(NPAs) were sent for virus isolation and identification.
The RSV and hMPV were identified by using two
methods in each individual sample. One was one-step
triplex qRT-PCR, the other was immunofluorescence ap-
proach to confirm the virus etiology after CPE forma-
tion. Ethical approval for the study was obtained from
the Chang Gung Memorial Hospital Ethics Committee
(99-2746B).
Nucleic acid extraction and triplex RT-PCR (qRT-PCR)
RNA was extracted from the supernatants of cultured vi-
ruses or nasopharyngeal aspirates by QIAamp viral RNA
mini kit (Qiagen, Valencia, CA, USA) according to the
manufactures instructions. All the RNA extraction pro-
cedure was conducted at BSL-2 laboratory. The qRT-
PCR of a final concentration of 12.5 μL Master Mix and
0.625 μL Enzyme Mix (TaqManR RNA-to-CT™ 1-Step
Kit, Applied Biosystems), 400 nM each primer; 200 nM
each probe, plus 7 μL of target RNA and was made up
to a volume of 25 μL with nuclease free water (Promega
Corp. Madison, USA). The reactions were incubated at
48 °C for 30 min, followed by 95 °C for 15 s (inactivation
reverse transcriptase/activation Taq polymerase), 40 cy-
cles of 95 °C for 15 s (denaturation), and 54 °C for 1 min
(annealing). RT-PCR assays were performed on an ABI
7500-fast (Applied Biosystem). If Ct >40 with lower con-
centration of virus, the amount of specimens was aug-
mented for increasing the concentration of RNA and
following One-step RT-PCR and direct sequencing.
Statistic analysis
The sensitivity and specificity of triplex qRT-PCR results
were analyzed by the receiver operating characteristic
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(ROC) method by SPSS software (SPSS statistical package
version 17, SPSS Inc., Chicago, IL). The linearity and re-
producibility for RSV and hMPV triplex qRT-PCR were
analyzed by and linear regression and absolute quantifica-
tion analysis (StepOnePlus software v2.3) provided by ABI
7500-fast PCR machine. Demographic data was analyzed
by Student’s “t” test and chi-square using SPSS software.
A p-value < 0.05 was considered significant.
Results
Assay specificity
A total of 86 virus culture stocks were used in specificity
testing. The different virus etiology including RSV (n = 20),
hMPV (n = 23), adenovirus (n = 10), enterovirus (n = 8), in-
fluenza A (n = 4), influenza B (n = 4), CMV (n = 5), HSV-1
(n = 3), parainfluenza type 1 (n = 3), parainfluenza type 2
(n = 3) and parainfluenza type 3(n = 3). No positive result
was obtained for non-RSV or non-hMPV. We also used
DEPC water as a negative control. The internal control
and positive-control reactions were positive. Results
showed that this one-step triplex qRT-PCR assay was spe-
cific and did not cross among RSV, hMPV and internal
control GAPHD, with each other. Primer pair RSVF/RSVR
and probe RSV-probe reacted only with RSV samples,
whereas primers hMPVF/hMPVR and probe hMPV-probe
allowed for the specific detection of hMPV isolates. The
sensitivity and specificity of the one-step triplex qRT-PCR
assay were both 100% when testing known viral stocks
(Table 2).
Assay linearity
Linearity of the one-step triplex qRT-PCR assay was de-
termined using serial 10-fold dilutions of RSV and
hMPV standard in viral transport medium (VTM) at the
following concentrations:102, 103, 104, 105, 106, 107,
108and 109 copies/reaction. The extracted DNA was
then analyzed by the triplex qRT-PCR assay. Three repli-
cates were tested in a single run at each concentration.
The relationship between the observed values and true
concentrations of analyses was examined through linear
regression. The limit of detection (LOD) of the triplex
qRT-PCR assay was 100 copies/reaction. Linear regres-
sion analysis of the Ct values against the log10 RSV and
hMPV plasmid concentration yielded R2 = 0.998 (Fig. 1a)
and 0.992 (Fig. 1b), respectively. The detail statistic
results were showed in Table 3.
Assay precision
Precision was estimated by performing the one-step trip-
lex qRT-PCR assay twice per day (each run separated by
a minimum of 2 h) over 2 days, by the same technician
using the same equipment and reagent lot numbers. The
intra-assay variation was assessed by testing 2 samples
with different viral loads (108 and 102 copies/reaction) 3
times in a single run, while the inter-assay variation was
assessed by testing the same samples 3 times in 2 separ-
ate runs. In our assay, the coefficient of variation (CV,
Table 2 Analytical sensitivity and specificity of triplex qRT-PCR
assay in 86 known virus culture supernatants
Virus Culture Stocks Cultural
Results No.(n)
Triplex qRT-PCR Results (n)
RSV+ hMPV+
RSV 20 20 0
hMPV 23 0 23
Adenovirus 10 0 0
Enterovirus 8 0 0
Influenza A virus 4 0 0
Influenza B virus 4 0 0
CMV 5 0 0
HSV-1 3 0 0
Parainfluenza virus 1 3 0 0
Parainfluenza virus 2 3 0 0
Parainfluenza virus 3 3 0 0
Total 86
Fig. 1 Analytical sensitivity of triplex qRT-PCR assay. a hMPV and (b)
RSV qRT-PCR assay. Fluorescence development was detected via
real-time detection in triplex qRT-PCR run by using a dilution range
of 109–102 DNA molecules/reaction of the hMPV and RSV molecular
standards (Graph generated by ESE quant tube scanner studio software)
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express imprecision) was lower than 5%. The intra-assay
CV ranged from 0.10 to 0.47%, while the inter-assay CV
ranged from 0.23 to 1.04% (Table 4).
Clinical evaluation
A total of 222 pediatric patients hospitalized with re-
spiratory symptoms were enrolled from November 2010
through August 2011. Study patients were 61% male and
39% female with a mean age of 0.91 years old (ranges
from32 days to 14 years old). The admitting diagnoses of
these infants were bronchiolitis (58%), brochopneumonia
(24%), and pneumonia (18%). Our one-step triplex qRT-
PCR results showed that the viral load of the RSV or
hMPV-positive samples from clinical specimens varied
over a wide range, presenting threshold between Ct 21
and 44 (21 and 44 cycles). As a result, 68 specimens
(30.6%) were found RSV positive, 18 specimens (8.1%)
were found hMPV positive by our one-step triplex qRT-
PCR. However, standard virus culture only detected 8
RSV positive cases (3.6%) and 0 hMPV cases (0%)
(Table 5). In detecting RSV, the major distribution of
threshold cycles ranged between Ct 21 and 25 (1,035,656
copies/ reaction ~77,992 copies/reaction). In detecting
hMPV, the major distribution of threshold cycles ranged
between Ct 31 and 35 (8395 copies/ reaction ~476 copies/
reaction) (Fig. 2).
qRT-PCR RSV positive patients were associated with
increased severe inflammation and pneumonia
The demographic data based on RSV/hMPV one-step
triplex qRT-PCR detection in 222 infants hospitalized
with respiratory symptoms showed that male patients
have higher percentages in RSV or hMPV infection. RSV
and hMPV infection cases were significantly associated
with severe lung inflammation based on chest X-Ray
index. Complication of pneumonia was observed in
more than 90% of RSV or hMPV infection patient
(Table 6). In addition, we found that RSV or hMPV in-
fection is not associated with C-reactive protein level, in-
dicating the importance of making definite diagnosis in
early intervention of RSV and hMPV associated adverse
effects, such as severe inflammation and pneumonia.
Discussion
In this study, we established a rapid and internally con-
trolled triplex qRT-PCR assay that can identify RSV and
Table 3 The linearity data for RSV and hMPV triplex qRT-PCR




hMPV −4.57 45.19 0.992 102–109 100
RSV −3.91 44.85 0.998 102–109 100
aLimit of detection









Intra-assay hMPV 108 3 13.90 0.033 0.24
102 3 35.69 0.170 0.47
RSV 108 3 15.80 0.015 0.10
102 3 39.10 0.112 0.29
Inter-assay hMPV 108 6 13.89 0.032 0.23
102 6 36.46 0.863 0.91
RSV 108 6 16.18 0.430 1.04
102 6 38.98 0.225 0.58
Table 5 Comparing of triplex qRT-PCR assay and virus culture in
nasopharyngeal aspirates from 222 patients hospitalized with
respiratory symptoms
Virus Culture Stocks Cultural
Results No.(n)
Triplex qRT-PCR Results (n)
RSV+ hMPV+
RSV 8 8 0
hMPV 0 0 0
Adenovirus 16 0 0
Enterovirus 8 0 0
Influenza A virus 1 0 0
Influenza B virus 1 0 0
CMV 3 0 0
Parainfluenza virus 1 3 0 0
Parainfluenza virus 2 1 0 0
Parainfluenza virus 3 13 0 0
aNVI 168 60 18
Total 222 68 18
aNVI Non virus identified using virus culture
Fig. 2 Ct values distribution of RSV and hMPV positive clinical
specimens. Our one-step triplex qRT-PCR results showed that the viral
load of the RSV or hMPV-positive samples from clinical specimens varied
over a wide range, presenting threshold cycles between 21 and 44. RSV
has a maximum occurrence detected between Ct 21 and 25, but hMPV
has a maximum occurrence between Ct 31 and 35
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hMPV virus in one reaction mixtures. The validation
parameters described here were in accordance with pro-
cedural and statistical methods as recommended in the
Validation of Analytical Procedures (Clinical and labora-
tory standard institute, CLSI 2009). The development of
fluorescent methods and instruments that allow real-time
monitoring of the amplification process is considered an
important step for molecular biology [19]. Real-time RT-
PCR has become a well-established procedure in terms of
rapid detection of nucleic acid targets. Incorporation of
housekeeping genes as internal control is important
to exclude false negative results due to incomplete
RNA extraction or inhibition of PCR. The optimized
assays reported here, allow specific and sensitive de-
tection of RSV and hMPV, as well as of an internal
amplification control. Furthermore, this method can
be multiplexed using different fluorogenic dyes for
the three probes.
In this current study, we determined the copy num-
bers of RSV and hMPV and internal control (GAPDH)
at the same time in one test sample. The procedures of
RNA extraction and reagent preparation and efficiency
of instruments could be monitor by triplex qRT-PCR in
one sample. Furthermore, this approach also reduced
the results of “false-negative” and cost down. However,
some groups detected target virus and internal control
by using duplex qRT-PCR that may increase the time-
consuming [20].
This triplex qRT-PCR provides several clinical advan-
tages. First, this method saves the time for diagnostic
performance, compared to virus culture. Second, our
method increased the accuracy of RSV and hMPV detec-
tion. The rapid and accurate RSV and hMPV detection
may help for early intervention of the related clinical
events or complications, such as severe lung inflamma-
tion and pneumonia.
Conclusion
Altogether, the three sets of primer/probe in the one-
step triplex qRT-PCR assay presented in this study is a
specific and sensitive diagnostic tool to rapid screening
for the detection of RSV and hMPV RNA. It is useful
method in routine laboratory diagnostics.
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Table 6 Demographic and clinical characteristics from 222
patients hospitalized with respiratory symptoms








F 62(45.6) 22(32.4) 3(16.7) 0.030*
M 74(54.4) 46(67.6) 15(83.3)
Age (years-old)
1.38 ± 1.89 1.15 ± 1.22 1.00 ± 1.29 0.119
CXR index (%)
N/A 27(19.9) 3(4.4) 4(22.2) 0.008*
Mild inflammation 43(31.6 18(26.5) 4(22.2)
Severe inflammation 66(48.5) 47(69.1) 10(55.6)
ICU treatment (%)
No 77(56.6) 47(69.1) 12(66.7) 0.118
Yes 59(43.4) 21(30.9) 6(33.3)
Pneumonia (%)
No 95(69.9) 6(8.8) 1(5.6) 0.001*
Yes 41(30.1) 62(91.2) 17(94.4)
Hypersomina (%)
No 131(96.3) 65(95.6) 18(100) 0.621
Yes 5(3.7) 3(4.4) 0(0)
Intubation (%)
No 134(98.5) 67(98.5) 17(94.4) 0.599
Yes 2(1.5) 1(1.5) 1(5.6)
CRP index (%)
N/A 8(5.9) 3(4.4) 0(0) 0.938
< 5 62(45.6) 34(50.5) 6(33.3)
Positive 66(48.5) 31(45.6) 12(66.7)
N/A not available, CXR index Chest X-Ray index, ICU Intensive care unit, CRP
C-reactive protein
*P < 0.05
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